Table 1.

Number of subjects for each biomarker (ranges included) and genotype

Variablen
PAH-albumin (range)249 (0.15-4.79)
ras p21 (range)254 (0-464.77)
CYP1A1 MspI258
CYP1A1 462258
CYP2D6A257
CYP2D6B257
NAT1*257
NAT2253
  • * The risk ratio comparison for NAT1 is based on any NAT1*10 allele versus all other genotypes.

  • The risk ratio comparison for NAT2 is based on slow acetylator genotypes versus rapid genotypes.